Literature DB >> 24204415

An easy direct arylation of 5-pyrazolones.

Hao Gong1, Yiwen Yang, Zechao Wang, Chunxiang Kuang.   

Abstract

A mild, efficient and catalytic ligand-free method for the direct arylation of 5-pyrazolones by Pd-catalyzed C-H bond activation is reported. The process smoothly proceeds and yields are moderate to excellent.

Entities:  

Keywords:  C–H bond activation; Pd(OAc)2; aryl halide; arylation; pyrazolone

Year:  2013        PMID: 24204415      PMCID: PMC3817516          DOI: 10.3762/bjoc.9.240

Source DB:  PubMed          Journal:  Beilstein J Org Chem        ISSN: 1860-5397            Impact factor:   2.883


Introduction

5-Pyrazolones are attracting considerable research interest because of their unique chemical properties and their structures that facilitate their application as biological and pharmaceutical intermediates and products [1-3]. Over the years, many of the biological activities of pyrazolones such as their antipyretic, analgesic [4-5], anti-inflammatory [6-7], antitumor [8-9], antiviral, antibacterial [10], and herbicidal [11] properties have been discovered and investigated. Pyrazolones are also potent inhibitors of telomerase, cyclooxygenase isoenzymes, platelet tromboxane synthesis, and prostanoid synthesis in humans [12-13]. Recently, pharmacologists have developed a novel class-II c-met inhibitor, whose structural unit is a pyrazolone ring [14]. The great medicinal significance and broad applications of pyrazolones prompted us to synthesize a new series of heterocyclic compounds containing the pyrazolone moiety. The reaction of pyrazolones with arylboronic acids is an attractive approach for the synthesis of arylpyrazolone [15-16]. However, it often needs pre-formation of halo-pyrazolones. Transition metal-catalyzed direct arylation of (hetero)arenes has emerged over the past few years as a rapidly growing field of syntheses [17-26]. The direct arylation of pyrazolones by using aryl halides offers a cleaner and more efficient method of meeting such goals and rare examples of such transformations have been described [15]. In this paper, we report a convenient and catalytic ligand-free synthesis of a series of 4-aryl-5-pyrazolones 3 from 5-pyrazolones 1 and aryl halides 2 (Scheme 1). The direct arylation of 5-pyrazolones by Pd-catalyzed C–H bond activation was utilized.
Scheme 1

Direct arylation of 5-pyrazolones.

Direct arylation of 5-pyrazolones.

Results and Discussion

We commenced this study by performing the direct arylation of phenazone (1a) in the presence of 2 equiv of iodobenzene (2a), 10 mol % of Pd(OAc)2 as a catalyst in acetonitrile in a sealed tube. The results are shown in Table 1. Gratifyingly, a 45% yield of the desired product 3a was achieved after stirring for 12 h at 90 °C. Encouraged by this preliminary result, we continued to optimize reaction conditions to further improve the chemical yield.
Table 1

Optimization of the synthesis of 3aa.


entryadditive (2 equiv)catalyst (0.1 equiv)solventT (°C)yield of 3ab

1nonePd(OAc)2CH3CN9045
2K2CO3Pd(OAc)2CH3CN9043
3Cs2CO3Pd(OAc)2CH3CN9035
4Na2CO3Pd(OAc)2CH3CN9027
5DBUPd(OAc)2CH3CN900
6K3PO4Pd(OAc)2CH3CN9049
7Ph3P (0.25 equiv)Pd(OAc)2CH3CN9042
8nonePd(OAc)2 (0.05 equiv)CH3CN9040
9nonePd(OAc)2 (0.02 equiv)CH3CN9032
10nonePd(OAc)2THF90traces
11nonePd(OAc)2DCE9031
12nonePd(OAc)2dioxane900
13nonePd(OAc)2benzene9022
14nonePd(OAc)2CH3CN250
15nonePd(OAc)2CH3CN6031
16nonePd(OAc)2CH3CN12035
17O2(1atm)Pd(OAc)2CH3CN9055
18K2S2O8Pd(OAc)2CH3CN905
19benzoquinonePd(OAc)2CH3CN900
20Cu(OAc)2Pd(OAc)2CH3CN9025
21Ag2CO3Pd(OAc)2CH3CN9080
22noneFeCl3 (0.3 equiv)CH3CN900
23noneCu(OAc)2 (0.2 equiv)CH3CN900
24nonenoneCH3CN900

aReaction conditions: 1.0 equiv of 1a and 2.0 equiv of 2a were stirred for 12 h. bIsolated yield.

Optimization of the synthesis of 3aa. aReaction conditions: 1.0 equiv of 1a and 2.0 equiv of 2a were stirred for 12 h. bIsolated yield. When 1a reacted with 2a in the presence of K2CO3 as a base in acetonitrile (90 °C, 12 h), the desired product 3a was generated in 43% yield (Table 1, entry 2). Changing K2CO3 to Cs2CO3, Na2CO3 and DBU (1,8-diazabicyclo(5.4.0)undec-7-ene), decreased the yield to 35%, 27% and 0%, respectively (Table 1, entry 3–5). Changing K2CO3 to K3PO4, the yield was increased to 49% (Table 1, entry 6). When Ph3P as a catalytic ligand was added to the reaction, the yield decreased to 42% (Table 1, entry 7). Reducing the dosage of Pd(OAc)2 to 0.05 equiv and 0.02 equiv, respectively, decreased the yield to 40% and 32% (Table 1, entries 8–9). Several solvents were examined under the conditions of entry 1. When the solvent was changed to THF, DCE, dioxane, and benzene, the yields decreased to trace, 31%, 0% and 22%, respectively (Table 1, entries 10–13). Other reaction parameters such as temperature and oxidants were also screened. When the reaction temperatures were 25 °C, 60 °C, and 120 °C, the yields decreased to 0%, 31% and 35%, respectively (Table 1, entries 14–16). When the reaction was under oxygen (1 atm) in a sealed tube and oxygen was used as an oxidant, product 3a was obtained in 55% yield (Table 1, entry 17). Changing the oxidant to K2S2O8, benzoquinone and Cu(OAc)2 decreased the yield to 5%, 0% and 25%, respectively (Table 1, entries 18–20). When Ag2CO3 was added to the reaction, the yield increased to 80% (Table 1, entry 21). Different catalysts were also examined. When Cu(OAc)2 or FeCl3 was used as a catalyst, or no catalyst was used in the reaction, product 3a was not obtained (Table 1, entries 22–24). Ultimately, the optimal reaction conditions were determined to be 0.1 equiv Pd(OAc)2 catalyst, 2.0 equiv Ag2CO3, acetonitrile, 90 °C, air atmosphere, 1:2 molar ratio of 1a to 2a, and 12 h reaction time. Under the optimized conditions (Table 1, entry 10), the scope of aryl halides was examined and the results are summarized in Table 2. The reactions of aryl halides 2 with phenyl moieties carrying either an electron-donating group such as methyl (2d and 2i), ethyloxy (2e) or an electron-withdrawing substituent such as methoxycarbonyl (2c and 2g), trifluoromethyl (2f) or formyl (2h) proceeded smoothly with moderate to good yields (Table 2, entries 3–10). When the phenyl moiety of the aryl halides 2 carried an electron-donating group, higher yields were obtained (Table 2, entries 4, 5, 9). On the other hand, an electron-withdrawing group on the phenyl moiety of the aryl halides (2c, 2f, 2g and 2h) provided 4-aryl-5-pyrazolones 3 in relatively low yields (Table 2, entries 3, 6–8). Entries 1 and 2 show that the yield of products was lower when using aryl bromide than when using aryl iodide, and 2-bromopyridine also provided 3i in moderate yield (Table 2, entry 10).
Table 2

Synthesis of 4-aryl- 5-pyrazolones 3.


entryAr–Xproductyield of 3 (%)a

12a3a80
22b3a67
32c3b71
42d3c81
52e3d84
62f3e71
72g3f78
82h3g70
92i3h82
102j3i64

aIsolated yield.

Synthesis of 4-aryl- 5-pyrazolones 3. aIsolated yield. Next, we investigated the scope of 5-pyrazolone 1 substrates. Table 3 shows that in most cases, the desired pyrazolones 3 were generated smoothly in moderate to good yields. When the phenyl moiety of pyrazolones 1 carried an electron-donating substituent such as methoxy (1b) and methyl (1c), the reactions provided pyrazolones 3 in high yields (Table 3, entries 1, 2). On the other hand, when pyrazolones 1 carried an electron-withdrawing substituent such as nitro (1f) and halogens (1g, 1i and 1k) in the aromatic portion, relatively low yields were obtained (Table 3, entries 5, 6, 8, 10). Compared with 5-pyrazolones containing a butyl or a phenyl substituent on the 3-position of the heterocycle (1d and 1e), the methyl (1a) on the same position resulted in a higher yield (Table 3, entries 3 and 4). The cause might be the steric hindrance of phenyl or butyl. The same trend could be seen from 1g to 1l (cf. 3o, 3q and 3s with 3p, 3r and 3t) (Table 3, entries 6–11).
Table 3

Synthesis of 4-phenyl-5-pyrazolones 3.


entry5-pyrazoloneproductyield of 3 (%)a

11b3j87
21c3k83
31d3l53
41e3m66
51f3n51
61g3o69
71h3p41
81i3q62
91j3r47
101k3s71
111l3t59

aIsolated yield.

Synthesis of 4-phenyl-5-pyrazolones 3. aIsolated yield.

Conclusion

In summary, we developed a mild, simple and efficient method for the direct arylation of 5-pyrazolones by Pd-catalyzed C–H bond activation. This approach resulted in the construction of 4-aryl-5-pyrazolones, which are important heterocyclic compounds used in medicinal and biological research. The investigations on the reaction mechanism are still in progress. Experimental details and characterization data for all compounds.
  20 in total

Review 1.  Recent advances in the transition metal-catalyzed twofold oxidative C-H bond activation strategy for C-C and C-N bond formation.

Authors:  Seung Hwan Cho; Ji Young Kim; Jaesung Kwak; Sukbok Chang
Journal:  Chem Soc Rev       Date:  2011-06-06       Impact factor: 54.564

2.  Catalytic dehydrogenative cross-coupling: forming carbon-carbon bonds by oxidizing two carbon-hydrogen bonds.

Authors:  Charles S Yeung; Vy M Dong
Journal:  Chem Rev       Date:  2011-03-09       Impact factor: 60.622

3.  Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents.

Authors:  Robert L Dow; Philip A Carpino; Denise Gautreau; John R Hadcock; Philip A Iredale; Dawn Kelly-Sullivan; Jeffrey S Lizano; Rebecca E O'Connor; Steven R Schneider; Dennis O Scott; Karen M Ward
Journal:  ACS Med Chem Lett       Date:  2012-03-21       Impact factor: 4.345

Review 4.  Mild analgesics. A review of their clinical pharmacology.

Authors:  W T Beaver
Journal:  Am J Med Sci       Date:  1965-11       Impact factor: 2.378

5.  Design, synthesis, and pharmacological activity of nonallergenic pyrazolone-type antipyretic analgesics.

Authors:  Naoto Uramaru; Hidenari Shigematsu; Akihisa Toda; Reiko Eyanagi; Shigeyuki Kitamura; Shigeru Ohta
Journal:  J Med Chem       Date:  2010-12-01       Impact factor: 7.446

6.  Controlling site selectivity in palladium-catalyzed C-H bond functionalization.

Authors:  Sharon R Neufeldt; Melanie S Sanford
Journal:  Acc Chem Res       Date:  2012-05-03       Impact factor: 22.384

7.  Inhibition of human neutrophil oxidative burst by pyrazolone derivatives.

Authors:  David Costa; Alexandra P Marques; Rui L Reis; José L F C Lima; Eduarda Fernandes
Journal:  Free Radic Biol Med       Date:  2005-10-21       Impact factor: 7.376

8.  Direct functionalization processes: a journey from palladium to copper to iron to nickel to metal-free coupling reactions.

Authors:  James J Mousseau; André B Charette
Journal:  Acc Chem Res       Date:  2012-10-26       Impact factor: 22.384

9.  Pyrazolone based TGFbetaR1 kinase inhibitors.

Authors:  Kevin Guckian; Mary Beth Carter; Edward Yin-Shiang Lin; Michael Choi; Lihong Sun; P Ann Boriack-Sjodin; Claudio Chuaqui; Benjamin Lane; Kam Cheung; Leona Ling; Wen-Cherng Lee
Journal:  Bioorg Med Chem Lett       Date:  2009-10-29       Impact factor: 2.823

10.  Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists.

Authors:  Maura Marinozzi; Andrea Carotti; Emanuele Sansone; Antonio Macchiarulo; Emiliano Rosatelli; Roccaldo Sardella; Benedetto Natalini; Giovanni Rizzo; Luciano Adorini; Daniela Passeri; Francesca De Franco; Mark Pruzanski; Roberto Pellicciari
Journal:  Bioorg Med Chem       Date:  2012-04-20       Impact factor: 3.641

View more
  2 in total

1.  Copper-Mediated Decarboxylative Coupling of 3-Indoleacetic Acids with Pyrazolones.

Authors:  Kangmei Wen; Yinrong Wu; Jiewen Chen; Jie Shi; Mulin Zheng; Xingang Yao; Xiaodong Tang
Journal:  ACS Omega       Date:  2022-02-02

2.  Polyfluoroalkylated antipyrines in Pd-catalyzed transformations.

Authors:  Evgeny V Shchegolkov; Yanina V Burgart; Daria A Matsneva; Sophia S Borisevich; Renata A Kadyrova; Iana R Orshanskaya; Vladimir V Zarubaev; Victor I Saloutin
Journal:  RSC Adv       Date:  2021-10-31       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.